ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Instrument makers continued to consolidate. Even as executives bemoaned government spending restraints in the U.S. and Europe, they eyed opportunities for future growth.
Capping weeks of rumors, Thermo Fisher Scientific announced in April that it would buy life sciences industry supplier Life Technologies for $13.6 billion, cementing Thermo Fisher’s role as one of the largest suppliers of scientific instruments and consumables. Life Technologies also brings a next-generation gene-sequencing business that could enlarge Thermo Fisher’s role in the growing disease diagnostics market.
In another consolidation move, Malvern Instruments acquired nanoparticle-tracking instrument maker NanoSight for $24 million. NanoSight CEO Jeremy Warren said Malvern “can provide us with more robust development capabilities” than his small firm would have on its own.
Agilent Technologies decided to split into two publicly traded companies by the end of 2014 to allow management to realize each new business’s full potential. The high-growth life sciences and applied businesses will keep the Agilent name. The more cyclical electronic measurement businesses have yet to be named.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter